Czechia – Immunosuppressive agents – Immunosuppressants TNF alpha inhibitors Infliximab s.c. filing II. (hereinafter also referred to as “contract” or “VZ”)
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The subject of the public contract is the regular supply of medicinal products for subcutaneous administration containing the active substance infliximab (ATC L04AB02) in the application form of a pre-filled pen for the treatment of patients in approved indications according to the SPC valid on the date of submission of tenders.
Related Procurement Opportunities
Similar tenders in Services